https://www.medisonpharma.com/news/pbs-listing-for-australians-with-hereditary-transthyretin-mediated-amyloidosis-with-polyneuropathy1/ 2025-03-17T08:45:20+00:00 https://www.medisonpharma.com/news/medison-pharma-and-alnylam-pharmaceuticals-announce-expansion-of-their-multi-regional-partnership-in-europe-and-israel-to-commercialize-rnai-therapeutics-in-additional-latam-and-apac-markets-including/ 2025-03-17T08:46:21+00:00 https://www.medisonpharma.com/news/pbs-listing-for-australians-with-hereditary-transthyretin-mediated-amyloidosis-with-polyneuropathy1-2/ 2025-03-17T08:47:16+00:00